Advertisement
Diagnostics
Subscribe to Diagnostics
View Sample

FREE Email Newsletter

Scientists Image Beginning Stages of Ovarian Cancer Growth with Time Lapse Technique

June 14, 2011 10:34 am | by AACR | News | Comments

Tweet • New model of time-lapse microscopy provides better visualization of metastatic processes. • Knowledge could allow for therapeutic targeting to prevent metastasis. • NOTE TO PRODUCERS/EDITORS: Video footage available. PHILADELPHIA - Scientists at Harvard University have created a...

Incidence of Gastrointestinal Disorders in Patients With Parkinson's Disease Increased Over Time and Impacted Clinical and Health Economic Outcomes

June 14, 2011 9:33 am | by Bio-Medicine.Org | News | Comments

BRUSSELS, June 14, 2011 /- A new study investigating the incidence and impact of gastrointestinal disorders (GID) among patients with Parkinson's disease (PD) found that patients who received both a PD diagnosis and a prior GID diagnosis appeared to have worse health outcomes compared to...

FDA Approves New Test To Help Determine if Breast Cancer Patients Are Candidates for Herceptin Treatment

June 14, 2011 9:33 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., June 14, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved a new genetic test that will help health care professionals determine if women with breast cancer are HER2-positive and, therefore, candidates for Herceptin (trastuzumab), a...

Advertisement

Mitsubishi Chemical Medience Corporation Receives 510(k) Clearance for PATHFAST® cTnI-II (cardiac Troponin I) Test in U.S.

June 13, 2011 9:32 pm | by Bio-Medicine.Org | News | Comments

TOKYO, June 14, 2011 /- Mitsubishi Chemical Medience Corporation announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) premarketing notification clearance to the PATHFAST® cTnI-II (cardiac Troponin I) diagnostic test, clearing the way for its sale in the...

Novelos Therapeutics to Present at the 5th Lippert/Heilshorn Life Sciences & Medical Technologies Virtual Conference on June 16

June 13, 2011 8:32 am | by Bio-Medicine.Org | News | Comments

MADISON, Wis., June 13, 2011 /- Novelos Therapeutics, Inc. (OTCBB: NVLT), a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, today announced that Harry S. Palmin, President and CEO of Novelos, will present at the 5th  Lippert/Heilshorn Life...

2011 mHealth Summit: Call for Research Abstracts and Speakers Now Open

June 13, 2011 8:32 am | by Bio-Medicine.Org | News | Comments

BETHESDA, Md., June 13, 2011 /- The Foundation for the National Institutes of Health, the mHealth Alliance, the Healthcare Information and Management Systems Society (HIMSS) and the National Institutes of Health (NIH) seek abstracts, presentations and speakers in the areas of research,...

PositiveID Corporation and Rogers Communications Partner to Improve Diabetes Management Through Innovative Mobile Technology

June 13, 2011 5:32 am | by PositiveID | News | Comments

PositiveID Corporation and Rogers Communications Partner to Improve Diabetes Management Through Innovative Mobile Technology

AACR's CR Magazine Honored With Four Prestigious Journalism Awards

June 13, 2011 5:32 am | by AACR | News | Comments

Tweet PHILADELPHIA - The American Association for Cancer Research is pleased to announce that CR – AACR's magazine for cancer survivors, their families and caregivers – won first place in the 2011 National Media Awards of the American Society of Colon and Rectal Surgeons. Separately, it...

Advertisement

FDA Clears New System to Perform Simultaneous PET, MRI Scans

June 10, 2011 9:32 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., June 10, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today cleared the Siemens Biograph mMR system, the first device to simultaneously perform a positron emission tomography scan, commonly known as PET scan, and a magnetic resonance imaging...

Volcano Corporation Presentation at William Blair Conference to be Webcast

June 10, 2011 4:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, June 10, 2011 /- Volcano Corporation (NASDAQ: VOLC ), a leading developer and manufacturer of precision intravascular diagnosis and therapy guidance tools designed to enhance the treatment of coronary and peripheral vascular disease, said today that it will be participating in...

Pancreatic Cancer Case

June 9, 2011 11:31 pm | by Diagnostic Imaging | News | Comments

An elderly patient is diagnosed with pancreatic cancer. What's your opinion on the case?

With Pediatric Sarcoma, No Need for Bone Scans. PET/CT Sufficient.

June 9, 2011 11:31 pm | by Diagnostic Imaging | News | Comments

Children with pediatric sarcoma can be spared the additional radiation of single photon emission computed tomography (SPECT). PET/CT imaging alone does the trick, according to a study presented this week at the Society of Nuclear Medicine annual meeting in San Antonio.

Enzymatics Reports Latest Growth Figures; Confirms Massachusetts' Emerging Role as Leading Bio-manufacturing Center

June 9, 2011 8:31 am | by Bio-Medicine.Org | News | Comments

BEVERLY, Mass., June 9, 2011 /- Enzymatics , Inc. announced today that the company, whose revenues have doubled every year since 2007, is forecasting triple the revenue in 2011 over 2010 figures.  It is also expanding its corporate offices and manufacturing facility in Beverly,...

Advertisement

Quest Diagnostics Wins Gold Medical Design Excellence Award (MDEA) for Diagnostic Innovation

June 9, 2011 8:31 am | by Bio-Medicine.Org | News | Comments

MADISON, N.J., June 9, 2011 /- Quest Diagnostics Incorporated (NYSE: DGX ), the world's leading provider of diagnostic testing, information and services, today announced that its Simplexa™ molecular diagnostic test on the 3M™ Integrated Cycler won a gold award in the in vitro...

Dr. Lowell S. Kabnick First to Use New VenaCure® 1470nm Laser

June 9, 2011 8:31 am | by Bio-Medicine.Org | News | Comments

MORRISTOWN, N.J., June 9, 2011 /- Dr. Lowell S. Kabnick, MD, RPhS, FACS, FACPh, Director of NYU Vein Center and internationally recognized authority and pioneer in the field of vascular surgery, is once again leading the way with breakthrough techniques, being the first in the country to...

National Comprehensive Cancer Network Guidelines Available in Elekta's MOSAIQ EMR

June 8, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

ATLANTA, June 8, 2011 /- Elekta has collaborated with the National Comprehensive Cancer Network® (NCCN®) to integrate the NCCN Clinical Practice Guidelines in Oncology ( NCCN Guidelines ™) into Elekta's MOSAIQ® Oncology Information System. The collaboration offers...

Dilon Diagnostics Launches Acella System

June 8, 2011 3:32 am | by Diagnostic Imaging | News | Comments

(Press Release) Dilon Diagnostics will introduce the latest advancement in molecular breast imaging (MBI) this week at the Society of Nuclear Medicine (SNM) Meeting in San Antonio, Texas, with the premiere of its FDA-cleared Dilon 6800® Acella Gamma Camera system.

SNM's Image of the Year Highlights Non-Oncology Utility

June 8, 2011 3:32 am | by Diagnostic Imaging | News | Comments

The Society of Nuclear Medicine's (SNM) 2011 Image of the Year illustrates the ability of positron emission tomography/computer tomography (PET/CT) scans to identify abnormal bone reaction in patients who have received spinal fixation hardware implants.

Dominion Diagnostics Supports Opioid Risk Management Program for Fourth Consecutive Year

June 8, 2011 3:32 am | by Bio-Medicine.Org | News | Comments

NORTH KINGSTOWN, R.I., June 8, 2011 /- Leading national medication monitoring company, Dominion Diagnostics, announces its support of Tufts Health Care Institute's (THCI) Program on Opioid Risk Management for a fourth consecutive year. Dominion's support of THCI's Program on Opioid Risk...

Data from Clinical Studies of bioTheranostics' CancerTYPE ID® and Breast Cancer Index(SM) Molecular Diagnostic Tests Presented at ASCO 2011 Annual Meeting

June 7, 2011 9:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, June 7, 2011 /- bioTheranostics, Inc., a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from clinical studies utilizing the company's CancerTYPE ID®, and Breast Cancer Index(SM). Data from the...

BGI Releases a Complete De Novo E. Coli O104 Genome Assembly and is Making Its Detection Kit Protocols and Synthesized Primers Freely Available to Worldwide Disease Control an...

June 7, 2011 9:32 am | by Bio-Medicine.Org | News | Comments

CAMBRIDGE, Mass. and SHENZHEN, China, June 7, 2011 /- Scientists worldwide have been working on the publicly available genomic sequences of the deadly E. coli O104 strain, which is causing the current health crisis in Germany and now spreading throughout Europe. To continue to speed the...

Vendor Neutral Archiving: What the NHS Should Expect

June 7, 2011 3:31 am | by RealWire | News | Comments

Free whitepaper from BridgeHead Software explains how vendor neutral archives (VNAs) can help the NHS reduce IT costs, increase efficiency and improve data protectionAshtead, UK - Tuesday 7th June - BridgeHead Software, a leader in healthcare data and storage management, today released a...

University Hospitals Seidman Cancer Center Opens: First Cancer Hospital in Northeast Ohio Offers Nation's Most Advanced Technology and Treatments

June 6, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

CLEVELAND, June 6, 2011 /- University Hospitals (UH) Seidman Cancer Center, Northeast Ohio's first and only freestanding cancer hospital, opens to patients on June 6. The ten-story, 150-bed cancer hospital will house the latest cancer-fighting treatments and technology – all in a...

Life Technologies Develops Fast and Accurate Test to Detect Europe's Deadly E. coli

June 6, 2011 3:32 am | by Bio-Medicine.Org | News | Comments

CARLSBAD, Calif., June 6, 2011 /- Life Technologies Corporation (NASDAQ: LIFE ) today announced that it has developed a custom test (assay) to accurately detect the E. coli bacterium that has killed at least 22 people and affected more than 2,100 worldwide, including four new cases...

MIMcloud 2.0, Cloud Computing for Medical Images, Shown at SIIM 2011

June 5, 2011 8:33 am | by Diagnostic Imaging | News | Comments

(Press Release) MIM Software is currently demonstrating MIMcloud 2.0 at their booth (#725/727) at the 2011 SIIM conference in Washington, D.C.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading